期刊文献+

心力衰竭患者内皮素和降钙素基因相关肽的变化及其与心功能的关系 被引量:3

The Change of Endothelin and Calcitonin Gene Related Peptide and its Relationship with Cardiac Function in Patients with CHF
下载PDF
导出
摘要 目的探讨充血性心力衰竭(CHF)患者血浆内皮素(ET)、降钙素基因相关肽CGRP的变化及其与心功能的关系。方法对入选的121例CHF患者测定了血浆ET和CGRP水平,超声心动图测量左室射血分数(LVEF),评价心功能,同时选择27例正常人作为对照组。结果CHF患者CGRP水平低于正常对照组,而血浆ET水平高于对照组(P<0.01);随着心功能恶化,CGRP水平逐渐降低,而血浆ET水平逐渐升高;相关分析表明;CHF患者血浆ET与CGRP水平和LVEF呈负相关,而血浆CGRP与LVEF呈正相关(P<0.01)。结论CHF患者血浆ET和CGRP参与了CHF的发生发展,其水平高低可反映CHF心功能损害程度。 Objective: To study the changes of endothelin (ET), calcitonin gene related peptide (CGRP) and the effect of them on cardiac function in patients with congestive heart failure (CHF). Methods: The plasma levels of ET and CGRP in 121 CHF patients were measured. Left ventricular ejection fraction (I.VEF) was from echocardiography. Results: The plasma levels of CGRP in patients with CHF were lower than that in control subjects. The plasma level of ET was higher than that in control subjects. The signifi- eant decreased in CGRP was correlated with increase of NYHA; and the levels of ET was on the eontrary. There were positive correlation between LVEF and the levels of CGRP (P〈0. 01), and a negative correlation between I.VEF and the levels of ET. Conclusions.Imbalance of the levels of ET and CGRP play roles in pathophysiologieal and pathogenetie mechanism in CHF, and correlated with the severity of cardiac function.
出处 《青海医药杂志》 2007年第4期7-9,共3页 Qinghai Medical Journal
基金 青海省科技厅自然科学基金项目资助课题(项目编号2006-N-149)部分研究内容
关键词 心力衰竭 内皮素 降钙素基因相关肽 Congestive heart failure Endothelin Calcitonin gene related peptide
  • 相关文献

参考文献5

二级参考文献21

  • 1Ho KK, Anderson KM, Kannel WB, et al. Survivalafter the onset of congestive heart failure in Framingham Heart Study subjects[J]. Circulation, 1993, 88(1):107- 115.
  • 2Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J]. Nature, 1988, 332(6163) :411 - 415.
  • 3Sutsch G, Kiowski W. Endothelin and endothelin receptor antagonist in heart failure [J]. J Cardiovasc Pharmacol,2000, 35(4 Suppl 2):S69- S73.
  • 4Turer A J, Tanzawak K. Mammalian member metallopeptidases: NEP, ECE, KELL and PEX[J]. FASEB J, 1997,11:355 - 364.
  • 5Webb DJ, Monge JC, Rabelink TJ, et al. Endothelin: new discoveries and rapid progress in the clinic [J]. Trends PharmacolSci, 1998, 19(1):5-8.
  • 6Masaki T. The endothelin family: an overview[J]. J Cardiovasc Pharmacol, 2000, 35(4 Suppl 2): S3 - S5.
  • 7Elshourbagy NA, Korman DR, Wu HL, et al. Molecular characterization and regulation of the human endothelin receptors[J]. J Biol Chem, 1993, 268(6) :3873 - 3879.
  • 8Karne S, Jayawickreme CK, Lerner MR. Cloning and characterization of an endothelin-3 specific receptor (ETc receptor) from Xenopus laevis dermal melanophores [J]. J Biol Chem, 1993, 268(25): 19126- 19133.
  • 9Ogawa Y, Nakao K, Arai H, et al. Molecular cloning of a non-isopeptide-selective human endothelin receptor [J].Biochem Biophys Res Commun, 1991, 178(1) :248 - 255.
  • 10Seo B, Oemar BS, Siebenmann R, et al. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels[J]. Circulation, 1994, 89(3): 1203 - 1208.

共引文献21

同被引文献40

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部